Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Anti-Human F11 (Xisomab 3G3)

Catalog #:   DHC04203 Specific References (13) DATASHEET
Host species: Human
Isotype: IgG
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Overview

Catalog No.

DHC04203

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Human

Isotype

IgG

Clonality

Monoclonal

Target

Plasma thromboplastin antecedent, PTA, Coagulation factor XI, F11, FXI

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P03951

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

Xisomab-3G3, Xisomab 3G3, Xisomab3G3, FXIa, Factor XI

Clone ID

Xisomab 3G3

Data Image
References

Genomic insights of the co-existence of blaOXA-23, blaOXA-91, blaNDM-1 harboring carbapenem-resistant Acinetobacter baumannii isolates from the intensive care units environment in Shanghai., PMID:40505723

Preventing Coagulation of Extracorporeal System During Hemodialysis., PMID:39503455

Metformin use is associated with lower risks of dementia, anxiety and depression: The Hong Kong diabetes study., PMID:38796398

Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial., PMID:37970718

Factor XI Inhibition With Heparin Reduces Clot Formation in Simulated Pediatric Extracorporeal Membrane Oxygenation., PMID:37801726

Development of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors., PMID:37422330

Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis., PMID:35638310

The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial., PMID:34086880

The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials., PMID:31216587

AB023, A Novel Antibody That Binds Factor XI and Blocks Its Activation by Factor XIIa., PMID:30917049

Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial., PMID:30700130

AB023, novel polyene antibiotics. II. Isolation and structure determination., PMID:8468240

AB023, novel polyene antibiotics. I. Taxonomy of the producing organism, fermentation and antifungal activity., PMID:8468239

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Anti-Human F11 (Xisomab 3G3) [DHC04203]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only